J. Sorensen
Chief Executive Officer chez GALERA THERAPEUTICS, INC.
Fortune : 46 486 $ au 31/03/2024
Provenance du réseau au premier degré de J. Sorensen
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 22 | |
Ascenta Therapeutics, Inc.
Ascenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA.
7
| Private Company | Pharmaceuticals: Major | 7 |
Public Company | Biotechnology | 4 | |
PlanetVerify Ltd.
PlanetVerify Ltd. Packaged SoftwareTechnology Services PlanetVerify Ltd. provides electronic monetary transactions services. The company was founded by Owen Sorensen, Farmar Sean, and Heather Kennedy in 2013 and is headquartered in Dublin, Ireland.
2
| Holding Company | Packaged Software | 2 |
Oncopia Therapeutics, Inc.
Oncopia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Oncopia Therapeutics LLC engages in biotechnology research. The company was founded in 2017 and is headquartered in Malvern, PA.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à J. Sorensen via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Jazz Pharmaceuticals (EUSA Pharma USA), Inc.
Jazz Pharmaceuticals (EUSA Pharma USA), Inc. BiotechnologyHealth Technology Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ. | Biotechnology | Director/Board Member Chief Executive Officer | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
Vion Pharmaceuticals, Inc.
Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Biotechnology | Director/Board Member | |
Wasatch Advisors, Inc.
Wasatch Advisors, Inc. Investment ManagersFinance Wasatch Advisors, Inc. (Wasatch) is an independent registered investment advisor headquartered in Salt Lake City, Utah. The firm was founded by Samuel Stewart and David Wagstaff in 1975. Wasatch provides discretionary investment advice for a variety of clients, which includes mutual funds, collective trusts, separately managed accounts and sub-advised products. | Investment Managers | Corporate Officer/Principal | |
MONSANTO | Wholesale Distributors | Corporate Officer/Principal Corporate Officer/Principal | |
PHASEBIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
ANNEXON, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Oncofusion Therapeutics, Inc.
Oncofusion Therapeutics, Inc. BiotechnologyHealth Technology Oncofusion Therapeutics, Inc. operates as oncology development company. It specializes in BET Bromodomain Inhibitors, ERG Inhibitors, EZH2-EED Inhibitors and MMSET/NSD2 Inhibitors. The company was founded in 2012 by Arul M. Chinnaiyan and Shaomeng Wang and is headquartered in Ann Arbor, MI. | Biotechnology | Founder | |
The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Doctorate Degree Graduate Degree | |
Drexel University | College/University | Undergraduate Degree Masters Business Admin | |
NEA Management Co. LLC
NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
Peking University
Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Undergraduate Degree | |
Case Western Reserve University
Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | College/University | Doctorate Degree | |
The University of Chicago | College/University | Masters Business Admin Corporate Officer/Principal | |
State University of New York at Buffalo | College/University | Doctorate Degree | |
University of California, Berkeley | College/University | Corporate Officer/Principal Masters Business Admin | |
University of California San Diego | College/University | Doctorate Degree Doctorate Degree | |
University of Delaware | College/University | Undergraduate Degree Undergraduate Degree | |
University of Illinois | College/University | Doctorate Degree Doctorate Degree | |
University of Michigan | College/University | Corporate Officer/Principal | |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Georgetown University | College/University | Corporate Officer/Principal | |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
Aspire IRB LLC
Aspire IRB LLC Miscellaneous Commercial ServicesCommercial Services Aspire IRB LLC operates as an independent review board that provides human subject protection oversight in clinical trials for life science companies. The private company is based in San Diego, CA and has subsidiaries in the United States. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Novartis Venture Funds (USA)
Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd | Investment Managers | Private Equity Investor Private Equity Investor | |
AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Jiangsu Yasheng Pharmaceutical Development Co. Ltd.
Jiangsu Yasheng Pharmaceutical Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Jiangsu Yasheng Pharmaceutical Development Co. Ltd. develops and produces pharmaceutical products. It focuses on research and development of structure-based molecule for cancer drugs. The company was founded by Dajun Yang, Ming Guo, and Shaomeng Wang in 2009 and is headquartered in Hong Kong. | Pharmaceuticals: Major | Founder Founder | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
UNC School of Medicine | College/University | Doctorate Degree | |
ASCENTAGE PHARMA GROUP INTERNATIONAL | Biotechnology | Director/Board Member Founder | |
MYOVANT SCIENCES LTD. | Biotechnology | Director/Board Member | |
New Enterprise Associates LLC
New Enterprise Associates LLC Investment ManagersFinance New Enterprise Associates LLC is an alternative investment manager. The private company is based in Timonium, MD. The company was founded in 1978 by Chuck Newhall, C. Richard Kramlich. | Investment Managers | Corporate Officer/Principal | |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Context Therapeutics LLC develops novel medicines for hormone responsive cancers. The company was founded by Martin Lehr in 2016 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Medsyn Biopharma LLC
Medsyn Biopharma LLC BiotechnologyHealth Technology Medsyn Biopharma LLC develops therapeutics for cancer. The company was founded by Shaomeng Wang and is headquartered in Malvern, PA. | Biotechnology | Founder | |
LUMOS PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Rogel Cancer Center: University of Michigan
Rogel Cancer Center: University of Michigan Medical/Nursing ServicesHealth Services Part of University of Michigan, Rogel Cancer Center provides healthcare services for cancer patients. | Medical/Nursing Services | Director/Board Member | |
Journal of Medicinal Chemistry | Corporate Officer/Principal | ||
Ascentage International Ltd. | Director/Board Member Director/Board Member | ||
CONTEXT THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistiques
Internationale
Etats-Unis | 44 |
Chine | 4 |
Royaume-Uni | 3 |
Hong Kong | 2 |
Sectorielle
Health Technology | 23 |
Consumer Services | 15 |
Finance | 5 |
Commercial Services | 4 |
Health Services | 3 |
Opérationnelle
Director/Board Member | 223 |
Corporate Officer/Principal | 101 |
Independent Dir/Board Member | 48 |
Chairman | 40 |
Founder | 23 |
Relations les plus connectées
Insiders | |
---|---|
Michael Barrett | 49 |
Michael Powell | 48 |
Frank Torti | 35 |
Norman Selby | 32 |
Henry Skinner | 29 |
Emmett Cunningham | 28 |
Thomas Dyrberg | 24 |
Campbell Murray | 23 |
Stephen K. Carter | 20 |
Robert Beardsley | 17 |
Joel F. Sussman | 16 |
Shao Meng Wang | 14 |
Lawrence Alleva | 12 |
Jason Fuller | 12 |
Jennifer Stacey | 12 |
- Bourse
- Insiders
- J. Sorensen
- Connexions Sociétés